BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 11354390)

  • 1. Pharmacokinetics and tolerability of extended-release clarithromycin.
    Guay DR; Gustavson LE; Devcich KJ; Zhang J; Cao G; Olson CA
    Clin Ther; 2001 Apr; 23(4):566-77. PubMed ID: 11354390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clarithromycin extended-release tablet: a review of its use in the management of respiratory tract infections.
    Darkes MJ; Perry CM
    Am J Respir Med; 2003; 2(2):175-201. PubMed ID: 14720016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open-label, randomized, multicenter, comparative study of the efficacy and safety of 7 days of treatment with clarithromycin extended-release tablets versus clarithromycin immediate-release tablets for the treatment of patients with acute bacterial exacerbation of chronic bronchitis.
    Weiss K; Vanjaka A;
    Clin Ther; 2002 Dec; 24(12):2105-22. PubMed ID: 12581548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
    Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
    Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of patients with acute exacerbation of chronic bronchitis.
    Adler JL; Jannetti W; Schneider D; Zhang J; Palmer R; Notario G
    Clin Ther; 2000 Dec; 22(12):1410-20. PubMed ID: 11192133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy of once daily, 5-day short-course therapy with clarithromycin extended-release versus twice daily, 7-day therapy with clarithromycin immediate-release in acute bacterial exacerbation of chronic bronchitis.
    Gotfried M; Notario G; Spiller J; Palmer R; Busman T
    Curr Med Res Opin; 2005 Feb; 21(2):245-54. PubMed ID: 15801995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the efficacy of extended-release clarithromycin tablets and amoxicillin/clavulanate tablets in the treatment of acute exacerbation of chronic bronchitis.
    Anzueto A; Fisher CL; Busman T; Olson CA
    Clin Ther; 2001 Jan; 23(1):72-86. PubMed ID: 11219481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clarithromycin (Biaxin) extended-release tablet: a therapeutic review.
    Gotfried MH
    Expert Rev Anti Infect Ther; 2003 Jun; 1(1):9-20. PubMed ID: 15482099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of a once-daily extended-release formulation of pramipexole in healthy male volunteers: three studies.
    Jenner P; Könen-Bergmann M; Schepers C; Haertter S
    Clin Ther; 2009 Nov; 31(11):2698-711. PubMed ID: 20110012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of adult patients with acute maxillary sinusitis.
    Murray JJ; Solomon E; McCluskey D; Zhang J; Palmer R; Notario G
    Clin Ther; 2000 Dec; 22(12):1421-32. PubMed ID: 11192134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of clarithromycin extended-release (ER) tablets in patients with AIDS.
    Jacobson MA; Nicolau DP; Sutherland C; Smith A; Aweeka F
    HIV Clin Trials; 2005; 6(5):246-53. PubMed ID: 16306031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy of clarithromycin modified-release and clarithromycin immediate-release formulations in the treatment of lower respiratory tract infection.
    Adam D; Glaser-Caldow E; Wachter J; Brueckner OJ; Hein J; Kroemer B; Hirsch J
    Clin Ther; 2001 Apr; 23(4):585-95. PubMed ID: 11354392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clarithromycin extended-release in community-acquired respiratory tract infections.
    Williams KN; Bishai WR
    Expert Opin Pharmacother; 2005 Dec; 6(16):2867-76. PubMed ID: 16318437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and Safety of Levetiracetam Extended-Release Tablets and Relative Bioavailability Compared with Immediate-Release Tablets in Healthy Chinese Subjects.
    Wang M; Wang M; Zhang Q; Zong S; Lv C
    Eur J Drug Metab Pharmacokinet; 2018 Aug; 43(4):405-413. PubMed ID: 29383569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role for 5-day, once-daily extended-release clarithromycin in acute bacterial exacerbation of chronic bronchitis.
    Gotfried M; Busman TA; Norris S; Notario GF
    Curr Med Res Opin; 2007 Feb; 23(2):459-66. PubMed ID: 17288699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).
    Swanson JM; Wigal SB; Wigal T; Sonuga-Barke E; Greenhill LL; Biederman J; Kollins S; Nguyen AS; DeCory HH; Hirshe Dirksen SJ; Hatch SJ;
    Pediatrics; 2004 Mar; 113(3 Pt 1):e206-16. PubMed ID: 14993578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two open-label, randomized, crossover studies assessing the bioequivalence of ofloxacin administered as immediate-and extended-release formulations in healthy subjects.
    Marier JF; Ducharme MP; DiMarco M; Di Spirito M; Morelli G; Tippabhotla SK; Badri N; Rampal A; Monif T
    Clin Ther; 2006 Dec; 28(12):2070-80. PubMed ID: 17296463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steady-state pharmacokinetics of a novel extended-release metformin formulation.
    Timmins P; Donahue S; Meeker J; Marathe P
    Clin Pharmacokinet; 2005; 44(7):721-9. PubMed ID: 15966755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of gabapentin after a single day and at steady state following the administration of gastric-retentive- extended-release and immediate-release tablets: a randomized, open-label, multiple-dose, three-way crossover, exploratory study in healthy subjects.
    Gordi T; Hou E; Kasichayanula S; Berner B
    Clin Ther; 2008 May; 30(5):909-16. PubMed ID: 18555937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.